Citation:1999
From Cancer Guidelines Wiki
Citation
Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. J Natl Cancer Inst 1999 Jan 6;91(1):66-72 Available from: http://www.ncbi.nlm.nih.gov/pubmed/9890172.
Critical appraisals
Compare quality appraisals for each clinical question
- [[Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?</span></span></span></span>»]] (compare critical appraisals)
Cited by
- What is the optimal systemic therapy for stage IV inoperable NSCLC?
- What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?
- What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?